With an increase in the number of prescriptions for oral targeted therapy, community pharmacists need to be knowledgeable about the mechanisms of action, administration, basic pharmacokinetics, and common side effects of these anti-cancer medications.
ONTarget is designed to help you confidently assess and manage the common side effects that targeted cancer therapies may induce in patients with cancer. Both community and hospital pharmacists will benefit in the:
- Appropriate prevention and management of common side effects that are associated with targeted cancer therapies
- Identification of key molecular targets that are blocked by targeted therapies in clinical use and may be targeted in future by newer agents
- Maintenance of patients on therapy and improvement of patient response and outcomes
CAPhO endorses the OnTarget Resource Guide.